Credit Suisse’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.48M | Sell |
199,920
-214
| -0.1% | -$2.79K | ﹤0.01% | 1718 |
|
|
2023
Q4 | $2.8M | Buy |
200,134
+681
| +0.3% | +$9.46K | ﹤0.01% | 1691 |
|
|
2023
Q3 | $2.95M | Sell |
199,453
-15,673
| -7% | -$220K | ﹤0.01% | 1592 |
|
|
2023
Q2 | $2.78M | Buy |
215,126
+24,055
| +13% | +$274K | ﹤0.01% | 1705 |
|
|
2023
Q1 | $1.87M | Buy |
191,071
+8,366
| +5% | +$89.3K | ﹤0.01% | 1915 |
|
|
2022
Q4 | $1.94M | Buy |
182,705
+22,813
| +14% | +$265K | ﹤0.01% | 1893 |
|
|
2022
Q3 | $1.67M | Sell |
159,892
-2,768
| -2% | -$36.1K | ﹤0.01% | 1965 |
|
|
2022
Q2 | $2.05M | Sell |
162,660
-17,069
| -9% | -$181K | ﹤0.01% | 1889 |
|
|
2022
Q1 | $1.95M | Buy |
179,729
+24,547
| +16% | +$298K | ﹤0.01% | 2097 |
|
|
2021
Q4 | $2.18M | Buy |
155,182
+3,493
| +2% | +$57.5K | ﹤0.01% | 2720 |
|
|
2021
Q3 | $2.92M | Buy |
151,689
+8,778
| +6% | +$117K | ﹤0.01% | 2523 |
|
|
2021
Q2 | $1.41M | Buy |
142,911
+36,713
| +35% | +$334K | ﹤0.01% | 3128 |
|
|
2021
Q1 | $1.04M | Sell |
106,198
-227,121
| -68% | -$1.87M | ﹤0.01% | 3290 |
|
|
2020
Q4 | $1.48M | Sell |
333,319
-187,902
| -36% | -$851K | ﹤0.01% | 3052 |
|
|
2020
Q3 | $2.25M | Buy |
521,221
+274,520
| +111% | +$1.96M | ﹤0.01% | 2346 |
|
|
2020
Q2 | $2.19M | Buy |
246,701
+140,090
| +131% | +$708K | ﹤0.01% | 2317 |
|
|
2020
Q1 | $376K | Sell |
106,611
-14,922
| -12% | -$69.2K | ﹤0.01% | 3279 |
|
|
2019
Q4 | $696K | Buy |
121,533
+68,920
| +131% | +$368K | ﹤0.01% | 3365 |
|
|
2019
Q3 | $187K | Buy |
52,613
+8,277
| +19% | +$32.1K | ﹤0.01% | 3874 |
|
|
2019
Q2 | $176K | Buy |
44,336
+3,688
| +9% | +$21.4K | ﹤0.01% | 3868 |
|
|
2019
Q1 | $298K | Buy |
40,648
+5,625
| +16% | +$55K | ﹤0.01% | 3597 |
|
|
2018
Q4 | $321K | Buy |
35,023
+9,418
| +37% | +$104K | ﹤0.01% | 3482 |
|
|
2018
Q3 | $318K | Sell |
25,605
-100,048
| -80% | -$1.35M | ﹤0.01% | 3492 |
|
|
2018
Q2 | $1.92M | Sell |
125,653
-4,770
| -4% | -$82.5K | ﹤0.01% | 2499 |
|
|
2018
Q1 | $2.59M | Buy |
130,423
+44,233
| +51% | +$764K | ﹤0.01% | 2216 |
|
|
2017
Q4 | $1.61M | Sell |
86,190
-128,238
| -60% | -$2.57M | ﹤0.01% | 2619 |
|
|
2017
Q3 | $4.61M | Buy |
214,428
+167,506
| +357% | +$2.65M | ﹤0.01% | 1823 |
|
|
2017
Q2 | $452K | Buy |
46,922
+12,423
| +36% | +$80.7K | ﹤0.01% | 3215 |
|
|
2017
Q1 | $205K | Sell |
34,499
-33,846
| -50% | -$163K | ﹤0.01% | 3616 |
|
|
2016
Q4 | $269K | Buy |
68,345
+13,125
| +24% | +$96.1K | ﹤0.01% | 3702 |
|
|
2016
Q3 | $579K | Buy |
55,220
+21,623
| +64% | +$311K | ﹤0.01% | 3346 |
|
|
2016
Q2 | $490K | Sell |
33,597
-30,285
| -47% | -$518K | ﹤0.01% | 3441 |
|
|
2016
Q1 | $1.23M | Buy |
63,882
+28,895
| +83% | +$584K | ﹤0.01% | 2571 |
|
|
2015
Q4 | $846K | Buy |
34,987
+10,644
| +44% | +$267K | ﹤0.01% | 2957 |
|
|
2015
Q3 | $597K | Sell |
24,343
-19,967
| -45% | -$565K | ﹤0.01% | 3271 |
|
|
2015
Q2 | $1.04M | Buy |
44,310
+12,065
| +37% | +$263K | ﹤0.01% | 3145 |
|
|
2015
Q1 | $723K | Sell |
32,245
-12,870
| -29% | -$247K | ﹤0.01% | 3256 |
|
|
2014
Q4 | $761K | Buy |
45,115
+33,812
| +299% | +$515K | ﹤0.01% | 3376 |
|
|
2014
Q3 | $162K | Sell |
11,303
-27,816
| -71% | -$401K | ﹤0.01% | 4207 |
|
|
2014
Q2 | $626K | Buy |
39,119
+16,654
| +74% | +$251K | ﹤0.01% | 3670 |
|
|
2014
Q1 | $406K | Buy |
22,465
+3,218
| +17% | +$59.7K | ﹤0.01% | 3871 |
|
|
2013
Q4 | $377K | Buy |
19,247
+10,566
| +122% | +$155K | ﹤0.01% | 3927 |
|
|
2013
Q3 | $103K | Sell |
8,681
-3,544
| -29% | -$44.6K | ﹤0.01% | 4103 |
|
|
2013
Q2 | $135K | Buy |
+12,225
| New | +$258K | ﹤0.01% | 3957 |
|
Other funds holding DVAX
DTC
CC
KCM
Credit Suisse's DVAX Position: Q1 2024 in Review
Credit Suisse reduced its Dynavax Technologies (DVAX) stake by 0.11% in Q1 2024, selling an estimated $2.79K and leaving 199,920 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.
Credit Suisse first reported a position in DVAX in Q2 2013 and has held it in 44 quarters since. The position peaked at $4.61M in Q3 2017. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.
- Credit Suisse held 199,920 shares of Dynavax Technologies worth $2.48M as of Q1 2024.
- Credit Suisse sold 214 Dynavax Technologies shares in Q1 2024, an estimated $2.79K.
- Dynavax Technologies made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1718 holding.
- Credit Suisse first reported a position in Dynavax Technologies in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Dynavax Technologies position peaked at $4.61M in Q3 2017.
- 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.